688809-95-2

Usage

Uses

Used in Pharmaceutical Industry:
(R)-3-Methoxypiperidine hydrochloride is used as an intermediate in the synthesis of pharmaceuticals for its unique stereochemistry and reactivity. Its specific arrangement of atoms allows for targeted interactions with biological molecules, potentially leading to the development of new drugs with improved efficacy and selectivity.
Used in Organic Chemistry:
(R)-3-Methoxypiperidine hydrochloride is used as a reagent in organic chemistry reactions due to its unique properties and reactivity. Its ability to participate in various chemical transformations can facilitate the synthesis of complex organic molecules, contributing to the advancement of chemical research and the development of novel compounds.
Used in Agrochemical Industry:
(R)-3-Methoxypiperidine hydrochloride may also find applications in the agrochemical industry as a precursor for the development of new pesticides or other agrochemical products. Its unique properties could potentially be harnessed to create more effective and targeted agrochemicals, improving crop protection and yield.

Upstream product

• 745066-86-8 (R)-tert-butyl 3-methoxypiperidine-1-carboxylate 

Relevant academic research and scientific papers

COMPOUNDS AND USES THEREOF

The present disclosure features compounds useful for the treatment of BAF complex-related disorders.

1,2-Di(cyclic)substituted benzene compounds

In one aspect, the present invention provides compounds having formula (1) or (100), a salt thereof or a hydrate of the foregoing, which compounds exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action, and are useful as therapeutic or prophylactic agents for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome; rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis. wherein R10 represents optionally substituted cycloalkyl, etc., R20-23 represent hydrogen, alkyl, alkoxy, etc., R30-32 represent hydrogen, alkyl, oxo, etc., and R40 represents optionally substituted alkyl, etc.

NOVEL QUINOXALINE DERIVATIVES

A quinoxalinone derivative of the formula (I): or a pharmaceutically acceptable salt or ester thereof, wherein; ???X is NH, S or the like; ???Y is O or the like; ???the partial structure is, for example, the formula: ???B1, B2, ....., Bn-1 and Bn, (in which n is 4 , 5 or 6) are each independently CH, N or the like; ???B'1, B'2, ....., B'n-1 and B'n (in which n is 4, 5 or 6) are each independently hydrogen or the like; and ???R is hydrogen, lower alkyl or the like.

ANTIPARASITIC TERPENE ALKALOIDS

The present invention relates to novel terpene alkaloids and their use as antiparasitic agents. The present invention also relates to an antiparasitic agent which comprises a terpene alkaloid compound of this invention as an effective ingredient in an antiparasitic formulation. More particularly, the present invention relates to derivatives of the terpene alkaloid (1S,2R,4aS,5R,8R,8aR)-2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(1-methylethenyl)-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl (2S,3aR,9bR)-6-chloro-9b-hydroxy-5-methyl-1,2,3,3a,5,9b-hexahydropyrrolo[2,3-c][2,1]benzoxazine-2-carboxylate. Pharmaceutical compositions comprising the same are also disclosed.